Logo image
Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic location
Journal article   Open access   Peer reviewed

Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic location

M A Pfaller, S A Messer, L Boyken, S Tendolkar, R J Hollis and D J Diekema
Journal of clinical microbiology, Vol.41(5), pp.2176-2179
05/2003
DOI: 10.1128/JCM.41.5.2176-2179.2003
PMCID: PMC154732
PMID: 12734273
url
https://doi.org/10.1128/JCM.41.5.2176-2179.2003View
Published (Version of record) Open Access

Abstract

We examined the susceptibilities to fluconazole of 559 bloodstream infection isolates of Candida glabrata and grouped the isolates by patient age and geographic location within the United States. Susceptibility of C. glabrata to fluconazole was lowest in the Pacific (44%) and East South Central (47%) regions and was highest in the West South Central region (82%) (regions are as designated by the U.S. Bureau of the Census). Isolates from pediatric patients were virtually all susceptible to fluconazole, whereas the highest frequency of resistance was observed in isolates from patients 16 to 64 years of age.
Antifungal Agents - pharmacology Fluconazole - pharmacology Age Factors United States Humans Middle Aged Child, Preschool Infant Candidiasis - microbiology Fungemia - microbiology Candidiasis - drug therapy Fungemia - drug therapy Candida glabrata - isolation & purification Adolescent Aged, 80 and over Adult Aged In Vitro Techniques Child Drug Resistance, Fungal Candida glabrata - drug effects

Details

Metrics

Logo image